Skip to main content
SpringerLink
Log in

Prophylaxis of Postoperative Nausea and Vomiting in Patients Scheduled for Breast Surgery

  • Review Article
  • Published:
Clinical Drug Investigation Aims and scope Submit manuscript

Abstract

Breast surgery performed under general anaesthesia is associated with a high incidence of postoperative nausea and vomiting (PONV). Between 60% and 80% of patients undergoing mastectomy (with axillary dissection) experience PONV.

Pharmacological approaches have been investigated to reduce PONV after breast surgery. Traditional antiemetics (droperidol and metoclopramide) are frequently used for the prevention of PONV during the first 24 hours after anaesthesia. The available non-traditional antiemetics that have been shown to be effective for prophylaxis against PONV are dexamethasone, clonidine, propofol and supplemental oxygen. Antiserotonins (ondansetron, granisetron, tropisetron, dolasetron and ramosetron) are highly effective for preventing PONV for 24 hours postoperatively, compared with traditional antiemetics. Ramosetron is effective for the long-term (up to 48 hours) prevention of PONV. Better results can be obtained by combining antiemetics, because they have different sites of action. Combination antiemetic therapy is often effective for preventing PONV after breast surgery. Combinations of an antiserotonin (granisetron or dolasetron) and droperidol or dexamethasone are more effective than monotherapy with antiserotonins. A non-pharmacological technique is acupuncture at the P6 (Nei-Kuan) point. Overall, these pharmacological and non-pharmacological approaches reduce the incidence of PONV following breast surgery.

Most of the published trials indicate improved prophylaxis of PONV following breast surgery by avoiding risk factors, and by using effective antiemetic agents in women scheduled for mastectomy (with axillary dissection). The clinician must weigh the benefits of using pharmacological and non-pharmacological approaches for PONV against the risk of occurrence of adverse events.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV
Table V

Similar content being viewed by others

References

  1. Harris JR, Lippman ME, Veronesi U, et al. Breast cancer. N Engl J Med 1992; 327: 319–28

    Article  PubMed  CAS  Google Scholar 

  2. Garfinkel L, Boring CC. Changing trends: an overview of cancer incidence and mortality. Cancer 1994; 74: 222–7

    Article  PubMed  CAS  Google Scholar 

  3. Balch CM, Singletary SE, Bland KI. Clinical decision-making in early breast cancer. Ann Surg 1993; 217: 207–25

    PubMed  CAS  Google Scholar 

  4. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992; 77: 162–84

    Article  PubMed  CAS  Google Scholar 

  5. Gan TJ, Meyer T, Apfel CC, et al. Consensus guidelines for managing postoperative nausea and vomiting. Anesth Analg 2003; 97: 62–71

    Article  PubMed  Google Scholar 

  6. Macario A, Weinger M, Truong P, et al. Which clinical anesthesia outcomes are both common and important to avoid: the perspective of a panel of expert anesthesiologists. Anesth Analg 1999; 88: 1085–91

    PubMed  CAS  Google Scholar 

  7. Koivuranta M, Laara E, Snare L, et al. A survey of postoperative nausea and vomiting. Anaesthesia 1997; 52: 443–9

    Article  PubMed  CAS  Google Scholar 

  8. Oddby-Muhrbeck E, Jakobsson J, Andersson L, et al. Postoperative nausea and vomiting: a comparison between intravenous and inhalation anaesthesia in breast surgery. Acta Anaesthesiol Scand 1994; 38: 52–6

    Article  PubMed  CAS  Google Scholar 

  9. Sadhasivam S, Saxena A, Kathivel S, et al. The safety and efficacy of prophylactic ondansetron in patients undergoing modified radical mastectomy. Anesth Analg 1999; 89: 1340–5

    PubMed  CAS  Google Scholar 

  10. Hammas B, Thorn SE, Wattwil M. Superior prolonged anti-emetic prophylaxis with a four-drug multimodal regimen — comparison with propofol or placebo. Acta Anaesthesiol Scand 2002; 46: 232–7

    Article  PubMed  CAS  Google Scholar 

  11. Sanchez LA, Hirsch JD, Carroll NV, et al. Estimation of the cost of postoperative nausea and vomiting in an ambulatory surgery center. J Res Pharm Econ 1995; 6: 35–44

    Google Scholar 

  12. Fujii Y, Tanaka H, Toyooka H. Prevention of nausea and vomiting in female patients undergoing breast surgery: a comparison with granisetron, droperidol, metoclopramide and placebo. Acta Anaesthesiol Scand 1998; 42: 220–4

    Article  PubMed  CAS  Google Scholar 

  13. Reihner E, Grunditz R, Giesecke K, et al. Postoperative nausea and vomiting after breast surgery: efficacy of prophylactic ondansetron and droperidol in a randomized placebo-controlled study. Eur J Anaesthesiol 2000; 17: 197–203

    PubMed  CAS  Google Scholar 

  14. Wattwil M, Thorn S-E, Lovqvist A, et al. Dexamethasone is as effective as ondansetron for the prevention of postoperative nausea and vomiting following breast surgery. Acta Anaesthesiol Scand 2003; 47: 823–7

    Article  PubMed  CAS  Google Scholar 

  15. Oddby-Muhrbeck E, Eksborg S, Bergendahl HTG, et al. Effects of clonidine on postoperative nausea and vomiting in breast cancer surgery. Anesthesiology 2002; 96: 1109–14

    Article  PubMed  CAS  Google Scholar 

  16. Uemura A, Fujii Y. Small dose of propofol for preventing emetic episodes in women undergoing mastectomy. Anesthesia Resuscitation 2003; 39: 103–5

    CAS  Google Scholar 

  17. Hagiya K, Fujii Y. Effective dose of small dose of propofol for preventing emetic episodes after mastectomy in women [in Japanese]. Masui to Sosei 2004; 40: 13–5

    Google Scholar 

  18. Purhonen S, Niskanen M, Wustefeld M, et al. Supplemental oxygen for prevention of nausea and vomiting after breast surgery. Br J Anaesth 2003; 91: 284–7

    Article  PubMed  CAS  Google Scholar 

  19. Purhonen S, Niskanen M, Wustefeld M, et al. Supplemental 80% oxygen does not attenuate postoperative nausea and vomiting after breast surgery. Acta Anaesthesiol Scand 2006; 50: 26–31

    Article  PubMed  CAS  Google Scholar 

  20. Sinha PK, Ambesh SP. Ondansetron in prophylaxis of postoperative nausea and vomiting in patients undergoing breast surgery: a placebo-controlled double blind study. J Indian Med Assoc 2004; 102: 73–9

    PubMed  Google Scholar 

  21. Fujii Y, Tanaka H, Toyooka H. Granisetron reduces incidence of nausea and vomiting after breast surgery. Acta Anaesthesiol Scand 1997; 41: 746–9

    Article  PubMed  CAS  Google Scholar 

  22. Fujii Y, Tanaka H, Toyooka H. Effective dose of granisetron in the reduction of nausea and vomiting after breast surgery. Acta Anaesthesiol Scand 1997; 41: 1167–70

    Article  PubMed  CAS  Google Scholar 

  23. Fujii Y, Tanaka H, Kawasaki T. Preoperative oral granisetron for the prevention of postoperative nausea and vomiting after breast surgery. Eur J Surg 2001; 167: 184–7

    Article  PubMed  CAS  Google Scholar 

  24. Janknegt R, Pinchaers JW, Rohof MH, et al. Double-blind comparative study of droperidol, granisetron and granisetron plus dexamethasone as prophylactic anti-emetic therapy in patients undergoing abdominal, gynaecological, breast or otolaryngological surgery. Anesthesia 1999; 54: 1059–68

    Article  CAS  Google Scholar 

  25. Dua N, Bhathagar S, Mishra S, et al. Granisetron and ondansetron for prevention of nausea and vomiting in patients undergoing modified radical mastectomy. Anesth Intensive Care 2004; 32: 761–4

    CAS  Google Scholar 

  26. Fujii Y, Tanaka H, Kawasaki T. A comparison of granisetron, droperidol, and metoclopramide in the treatment of established nausea and vomiting after breast surgery: a double-blind, randomized, controlled trial. Clin Ther 2003; 25: 1142–9

    Article  PubMed  CAS  Google Scholar 

  27. Chan MTV, Chui PT, Ho WS, et al. Single-dose tropisetron for preventing postoperative nausea and vomiting after breast surgery. Anesth Analg 1998; 87: 931–5

    PubMed  CAS  Google Scholar 

  28. Zeid HA, Al-Gahamdi, Abdul-Hadi M. Dolasetron decreases postoperative nausea and vomiting after breast surgery. Breast J 2002; 4: 216–21

    Article  Google Scholar 

  29. Loewen P, Lamb S, Clugston P. Randomized, double-blind trial of dolasetron versus droperidol for prophylaxis of postoperative nausea and vomiting in patients undergoing TRAM flap breast reconstruction surgery. Ann Plast Surg 2003; 51: 472–7

    Article  PubMed  Google Scholar 

  30. Fujii Y, Tanaka H, Kawasaki T. Benefits and risks of granisetron versus ramosetron for nausea and vomiting after breast surgery: a randomized, double-blinded, placebo-controlled trial. Am J Ther 2004; 11: 278–82

    Article  PubMed  Google Scholar 

  31. Fujii Y, Toyooka H, Tanaka H. Granisetron-droperidol combination for the prevention of postoperative nausea and vomiting in female patients undergoing breast surgery. Br J Anaesth 1998; 81: 387–9

    Article  PubMed  CAS  Google Scholar 

  32. Fujii Y, Tanaka H, Toyooka H. Prophylactic antiemetic therapy with granisetron-dexamethasone combination in women undergoing breast surgery. Acta Anaesthesiol Scand 1998; 42: 1038–42

    Article  PubMed  CAS  Google Scholar 

  33. Piper SN, Triem JG, Rohm KD, et al. Prevention of postoperative nausea and vomiting: randomised comparison of dolasetron versus dolasetron plus dexamethasone. Anaesthesist 2003; 52: 120–6

    Article  PubMed  CAS  Google Scholar 

  34. Streitberger K, Diefenbacher M, Bauer A, et al. Acupuncture compared to placebo-acupuncture for postoperative nausea and vomiting prophylaxis: a randomised placebo-controlled patient and observer blind trial. Anaesthesia 2004; 59: 142–9

    Article  PubMed  CAS  Google Scholar 

  35. Gan TJ, Jiao KR, Zenn M, et al. A randomized controlled comparison of electro-acupoint stimulation or ondansetron versus placebo for the prevention of postoperative nausea and vomiting. Anesth Analg 2004; 99: 1070–5

    Article  PubMed  Google Scholar 

  36. Apfel CC, Greim CA, Haubitz I, et al. A risk score to predict the probability of postoperative vomiting in adults. Acta Anaesthesiol Scand 1998; 42: 495–501

    Article  PubMed  CAS  Google Scholar 

  37. Sinclair DR, Chung F, Mezei G. Can postoperative nausea and vomiting be predicted. Anesthesiology 1999; 91: 109–18

    Article  PubMed  CAS  Google Scholar 

  38. Apfel CC, Laara E, Koivuranta M, et al. A simplified risk score for predicting postoperative nausea and vomiting: conclusion from cross-validations between two centers. Anesthesiology 1999; 91: 693–700

    Article  PubMed  CAS  Google Scholar 

  39. Smessaert A, Schehr CA, Artusio Jr JF. Nausea and vomiting in the immediate postoperative period. JAMA 1959; 170: 2072–6

    Article  CAS  Google Scholar 

  40. Jenkins JC, Lahay D. Central mechanisms of vomiting related to catecholamine response: anaesthetic implication. Can Anaesth Soc J 1971; 18: 434–41

    Article  PubMed  CAS  Google Scholar 

  41. Perreault L, Normandin N, Plamondon L, et al. Middle ear pressure variations during nitrous oxide-oxygen anesthesia. Can Anaesth Soc J 1982; 29: 428–34

    Article  PubMed  CAS  Google Scholar 

  42. Egar EI II, Saidman LJ. Hazards of nitrous oxide anesthesia in bowel obstruction and pneumothorax. Anesthesiology 1965; 26: 61–6

    Article  Google Scholar 

  43. Hartung J. Twenty-four of twenty-seven studies show a greater incidence of emesis with nitrous oxide than with alternative anesthetics. Anesth Analg 1996; 83: 114–6

    PubMed  CAS  Google Scholar 

  44. Vanacker BF. The impact of nitrous oxide on postoperative nausea and vomiting after desflurane anesthesia for breast surgery. Acta Anaesth Belg 1999; 50: 77–81

    PubMed  CAS  Google Scholar 

  45. Sneyd JR, Carr A, Byrom WD, et al. A meta-analysis of nausea and vomiting following maintenance of anaesthesia with propofol or inhalational agents. Eur J Anaesthesiol 1998; 15: 433–45

    PubMed  CAS  Google Scholar 

  46. Loeser EA, Bennet G, Stanley TH, et al. Comparison of droperidol, haloperidol and prochlorperazine as postoperative anti-emetics. Can Anaesth Soc J 1979; 26: 125–7

    Article  PubMed  CAS  Google Scholar 

  47. Harrington RA, Hamilton CW, Brogden RN, et al. Metoclopramide: an update review of its pharmacological properties and clinical use. Drugs 1983; 25: 451–94

    Article  PubMed  CAS  Google Scholar 

  48. McCormick C. FDA alert: current FDA report on droperidol status and basis for ‘black box’ warning. Am Soc Anesthesiologists Newsletter 2002; 66: 19–20

    Google Scholar 

  49. Habib AS, Gan TJ. Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003; 96: 1377–9

    Article  PubMed  Google Scholar 

  50. Henzi I, Walder B, Tramer MR. Metoclopramide in the prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized, placebo-controlled studies. Br J Anaesth 1999; 83: 761–71

    Article  PubMed  CAS  Google Scholar 

  51. Henzi I, Walder B, Tramer MR. Dexamethasone for prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000; 90: 186–94

    Article  PubMed  CAS  Google Scholar 

  52. Aasoboe V, Raeder JC, Groegaard B. Betamethasone reduces postoperative pain and nausea after ambulatory surgery. Anesth Analg 1998; 87: 319–23

    Google Scholar 

  53. Maze M, Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology 1991; 74: 581–605

    Article  PubMed  CAS  Google Scholar 

  54. Smith I, White PF, Nathanson M, et al. Propofol: an update on its clinical use. Anesthesiology 1994; 81: 1005–43

    Article  PubMed  CAS  Google Scholar 

  55. Borgeat A, Wilder-Smith OHG, Saiah M, et al. Subhypnotic doses of propofol possess direct antiemetic properties. Anesth Analg 1992; 74: 539–41

    Article  PubMed  CAS  Google Scholar 

  56. Ostman PL, Faure E, Glosten B, et al. Is the antiemetic effect of the emulsion formulation of propofol due to the lipid emulsion. Anesth Analg 1990; 71: 536–40

    PubMed  CAS  Google Scholar 

  57. Cechetto DF, Diab T, Gibson CJ, et al. The effects of propofol in the area postrema of rats. Anesth Analg 2001; 92: 934–42

    Article  PubMed  CAS  Google Scholar 

  58. Bunce KT, Tyers MB. The role of 5-HT in postoperative nausea and vomiting. Br J Anaesth 1992; 69: 60S–2S

    Article  PubMed  CAS  Google Scholar 

  59. Tolan MM, Fuhrman TM, Tsueda K, et al. Perioperative extrapyramidal reactions associated with ondansetron. Anesthesiology 1999; 90: 340–1

    Article  PubMed  CAS  Google Scholar 

  60. Sprung J, Choudhry FM, Hall BA. Extrapyramidal reactions to ondansetron: cross-reactivity between ondansetron and prochlorperazine. Anesth Analg 2003; 96: 1374–6

    Article  PubMed  Google Scholar 

  61. Kasinath NS, Malak O, Tetzlaff J. Atrial fibrillation after ondansetron for the prevention and treatment of postoperative nausea and vomiting: a case report. Can J Anesth 2003; 50: 229–31

    Article  PubMed  Google Scholar 

  62. Baguley WA, Hay WT, Mackie KP, et al. Cardiac dysrhythmias associated with the intravenous administration of ondansetron and metoclopramide. Anesth Analg 1997; 84: 1380–1

    PubMed  CAS  Google Scholar 

  63. Rowbotham DJ. Current management of postoperative nausea and vomiting. Br J Anaesth 1992; 69: 46S–59S

    Article  PubMed  CAS  Google Scholar 

  64. Smith DB, Newlands ES, Rustin GJS, et al. Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapy. Lancet 1991; 338: 487–90

    Article  PubMed  CAS  Google Scholar 

  65. Young S. Mechanism of decline in rat brain 5-hydroxytryptamine after induction of liver tryptophan pyrolase by hydrocortisone: role of tryptophan catabolism and kynureine synthesis. Br J Pharmacol 1981; 74: 695–700

    Article  PubMed  CAS  Google Scholar 

  66. Frederikson M, Mursti T, Furst C, et al. Nausea in cancer chemotherapy is inversely related to urinary cortisol excretion. Br J Cancer 1992; 65: 779–80

    Article  Google Scholar 

  67. Sager S. The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control. Cancer Treat Rev 1991; 18: 95–135

    Article  Google Scholar 

  68. Al-Sadi M, Newman B, Julious SA. Acupuncture in the prevention of postoperative nausea and vomiting. Anaesthesia 1997; 52: 658–61

    Article  PubMed  CAS  Google Scholar 

  69. Stein DJ, Birnbach DJ, Danzer BI, et al. Acupressure versus intravenous metoclopramide to prevent nausea and vomiting during spinal anesthesia for cesarean section. Anesth Analg 1997; 84: 342–5

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

No sources of funding were used to assist in the preparation of this review. The author has no conflicts of interest that are relevant to the content of this review.

Author information

Authors and Affiliations

  1. First Department of Anesthesiology, Toho University School of Medicine, Ohmori-Nishi, Ohta-ku, Tokyo, 6-11-1, 143-8541, Japan

    Yoshitaka Fujii

Authors
  1. Yoshitaka Fujii
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshitaka Fujii.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fujii, Y. Prophylaxis of Postoperative Nausea and Vomiting in Patients Scheduled for Breast Surgery. Clin. Drug Investig. 26, 427–437 (2006). https://doi.org/10.2165/00044011-200626080-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00044011-200626080-00001

Keywords

Search

Navigation